ArticleCancer medicine2024

Short-Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Study.

Jin Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.